News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 217–252
- Matches
- 800
- Sources here
- 22
- Companies here
- 19
Active search
800 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Quest Diagnostics Incorporated $DGX Holdings Trimmed by Empowered Funds LLC
Empowered Funds LLC significantly reduced its stake in Quest Diagnostics (NYSE:DGX) by 61.5% in the first quarter, selling over 15,000 shares. Despite this, institutional investors still own a substantial 88.06% of the company's stock. Quest Diagnostics exceeded Q1 earnings and revenue expectations, and analysts …
Guinness owner Diageo targets $1B in cost savings
This story was originally published on Food Dive. To receive daily news and insights, subscribe to our free daily Food Dive newsletter. Dive Brief: Guinness owner Diageo unveiled a $1 billion savings plan during the next three years to turn around the business. The …
Carriage Services Inc (CSV) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of
Co-Diagnostics' Test Filing Draws on 1,400 Patients
Co-Diagnostics (Nasdaq: CODX) has submitted a Dual FDA 510(k) premarket notification and a concurrent CLIA Waiver by Application for its Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test. This test is designed for use on the Co-Dx PCR Pro instrument in decentralized …
Co-Diagnostics submits FDA 510(k) for respiratory test
Co-Diagnostics, Inc. has submitted a Dual 510(k) premarket notification and a concurrent CLIA Waiver by Application to the FDA for its Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test. This submission aims to allow the test to be used in decentralized point-of-care …
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
Niagen Bioscience has partnered with Evotec to advance the preclinical development of NB4168, their lead investigational candidate for rare pediatric diseases, particularly Ataxia Telangiectasia (A-T). Evotec will conduct pharmacokinetic, pharmacodynamic, and bioanalytical studies at their Verona campus, utilizing their INDiGO platform to accelerate the …
IAMGOLD Corp. (IAG) Misses Q2 EPS by 12c
IAMGOLD Corp. (IAG) reported its Q2 earnings, missing analyst expectations for both EPS and revenue. The company posted an EPS of $0.42, which was $0.12 lower than the estimated $0.54, and revenue came in at $856.9 million against a consensus estimate of $932.83 million.
IAMGOLD Non-GAAP EPS of $0.42 misses by $0.02, revenue of $856.9M misses by $21.21M
* IAMGOLD press release [https://seekingalpha.com/filing/309923403] (IAG [https://seekingalpha.com/symbol/IAG]): Q2 Non-GAAP EPS of $0.42 misses by $0.02. * Revenue of $856.9M (+47.5% Y/Y) misses by $21.21M. * Attributable gold production was 188,100 ounces in the second quarter and 371,700 ounces year-to-date (“YTD”), with the Company on …
Niagen Bioscience launches Tru Niagen on Walmart.com
Niagen Bioscience has launched its Tru Niagen NAD+ supplement on Walmart.com, making its healthy-aging product more widely available. The initial offering includes 300 mg bottles, with more products to follow. Tru Niagen, which contains patented nicotinamide riboside, is backed by numerous human clinical studies …
Diageo (LSE:DGE) On Results And Guinness Spend As Fair Value Still Sits Higher
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Diageo (LSE:DGE) has drawn fresh attention after reporting full year results to June 30, 2026, showing softer sales, revenue and earnings alongside a major cost …
IAMGOLD appoints Catherine McLeod-Seltzer to board
IAMGOLD Corporation has announced that Catherine McLeod-Seltzer will join its board of directors on September 1, 2026. McLeod-Seltzer brings over 40 years of mining industry experience, including executive roles and board memberships at companies like Teck Resources Limited and Kinross Gold Corporation. Her extensive …
CARRIAGE SERVICES INC 2026: Revenue $102.95M, EPS $0.77— 10-Q Summary
CARRIAGE SERVICES INC (CSV) reported its Q2 2026 results, showing a slight increase in revenue to $102.95M and a rise in diluted EPS to $0.77. The company saw modest year-over-year growth in net income, driven by improved cemetery performance and operational efficiencies despite declining …
IAMGOLD Reports Second Quarter 2026 Results
IAMGOLD Corporation reported strong financial and operating results for the second quarter ended June 30, 2026, producing 188,100 ounces of gold and generating $507.3 million of adjusted EBITDA, staying on track for its full-year guidance of 720,000 to 820,000 ounces. The company strengthened its …
IAMGold earnings up next: Can margins hold amid gold retreat?
IAMGold Corporation is preparing to report its second-quarter earnings, with investors focused on whether the gold miner can maintain strong profit margins despite a significant retreat in gold prices. Analysts anticipate earnings of 50 cents per share on $932.8 million in revenue, a sequential …
Diageo PLC Stock (DEO) Moved Up by 5.04% on Aug 6: What Investors Need To Know
Diageo PLC (DEO) stock increased by 5.04% on August 6, outperforming the Food & Beverages sector. This rise is attributed to strong performance in premium spirits, normalized inventory levels, strategic pricing, and supply chain optimizations. The company reported $20.25 billion in annual revenue, and …
Sei Investments Co. Increases Holdings in Niagen Bioscience, Inc. $NAGE
Sei Investments Co. significantly increased its stake in Niagen Bioscience, Inc. (NASDAQ:NAGE) by 155.6% in the first quarter, now owning 971,574 shares valued at $4.29 million. Despite this increased institutional interest, Niagen Bioscience shares opened down 14.7% near their 52-week low, with quarterly earnings …
CDIO | Cardio Diagnostics Holdings Inc. Executive Compensation
This article provides an overview of Cardio Diagnostics Holdings Inc. (CDIO) executive compensation, noting that specific figures for the highest-paid executive were unavailable at the time of publication. It also details various financial and analytical data points for CDIO, including institutional holdings, insider trading, …
Lucid Diagnostics Inc (LUCD) News, Articles, Events & Latest Updates
This article provides a compilation of recent news and updates regarding Lucid Diagnostics Inc. (LUCD), including coverage policies for its EsoGuard test, upcoming investor conference participations, and quarterly earnings reports from related companies. It also mentions a price target reduction for LUCD despite expected …
Diageo PLC (DEO) (FY 2026) Earnings Call Highlights: Mixed Results with Strong Cash Flow and ...
This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strong free cash flow of $3.2 billion, up $463 million year-over-year, enabling debt reduction. Organic …